Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign – with more than $750 million already raised – that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.
The “We’re Changing Medicine” campaign is the largest in Weill Cornell Medicine’s history and its first campaign in decades to advance and synergize all three institutional missions: to care, discover and teach. Exemplifying Cornell’s mission of doing the greatest good, the new campaign will instill this essential value in the next generation of physicians and scientists, who will shape an innovative and equitable future of medicine.
Powering the “We’re Changing Medicine” campaign is $215 million in foundational gifts from several of the institution’s most long-standing benefactors. In 2019, during the campaign’s quiet phase, a lead gift from The Starr Foundation, chaired by Weill Cornell Medicine Board of Fellows member Maurice R. Greenberg, in partnership with gifts from The Weill Family Foundation, created by Joan and Sanford I. Weill, campaign co-chair and Board of Fellows chairman emeritus, and other generous donors together totaled $160 million. This established a game-changing scholarship program that provides debt-free education to medical students in financial need.
A $55 million gift in 2020 from Board of Fellows vice chair and campaign co-chair Jeffrey Feil and the Feil family will support the construction of a new student residence hall four blocks from the institution’s main campus, which will further enhance Weill Cornell Medicine’s student experience.
Read the full story on the Weill Cornell Medicine website.
